2023-2029 Global Recombinant Hirudin Industry Research & Trends Analysis Report
According to YH Research, the global market for Recombinant Hirudin should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Recombinant Hirudin market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Recombinant Hirudin market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, 12000ATU/mg segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Thrombosis Disease has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Recombinant Hirudin include Abbott, The Medicines Company, Teva Pharmaceutical, Pfizer, Pentapharm, PrimeGene, Aniara Diagnostica, Bioassay Technology Laboratory and Novus Biologicals, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Hirudin is the most potent natural inhibitor of thrombin. Unlike antithrombin, hirudin binds to and inhibits only the activity of thrombin, with a specific activity on fibrinogen. Therefore, hirudin prevents or dissolves the formation of clots and thrombi (i.e., it has a thrombolytic activity), and has therapeutic value in blood coagulation disorders, in the treatment of skin hematomas and of superficial varicose veins, either as an injectable or a topical application cream. In some aspects, hirudin has advantages over more commonly used anticoagulants and thrombolytics, such as heparin, as it does not interfere with the biological activity of other serum proteins, and can also act on complexed thrombin.
It is difficult to extract large amounts of hirudin from natural sources, so a method for producing and purifying this protein using recombinant biotechnology has been developed. This has led to the development and marketing of a number of hirudin-based anticoagulant pharmaceutical products. Several other direct thrombin inhibitors are derived chemically from hirudin.
Recombinant Hirudin is derived from yeast and the polypeptide chain contains 65 amino acids and its Mw is 6979.5 Dalton which is identical to natural Hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. The Recombinant Hirudin is purified by proprietary chromatographic techniques.
This report aims to provide a comprehensive study of the global market for Recombinant Hirudin. Report Highlights:
(1) Global Recombinant Hirudin market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Recombinant Hirudin market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Recombinant Hirudin market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Recombinant Hirudin segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Recombinant Hirudin segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Recombinant Hirudin, capacity, production and trends.
(7) Recombinant Hirudin industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
12000ATU/mg
16000ATU/mg
Market segment by application, can be divided into
Thrombosis Disease
Tumor Disease
Market segment by players, this report covers
Abbott
The Medicines Company
Teva Pharmaceutical
Pfizer
Pentapharm
PrimeGene
Aniara Diagnostica
Bioassay Technology Laboratory
Novus Biologicals
Merck KGaA
1 Market Overview
1.1 Recombinant Hirudin Definition
1.2 Global Recombinant Hirudin Market Size and Forecast
1.2.1 By Revenue, Global Recombinant Hirudin Market Size, 2018-2029
1.2.2 By Sales Volume, Global Recombinant Hirudin Market Size, 2018-2029
1.2.3 Global Recombinant Hirudin Price Trend, 2018-2029
1.3 China Recombinant Hirudin Market Size and Forecast
1.3.1 By Revenue, China Recombinant Hirudin Market Size, 2018-2029
1.3.2 By Sales Volume, China Recombinant Hirudin Market Size, 2018-2029
1.3.3 China Recombinant Hirudin Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Recombinant Hirudin Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Recombinant Hirudin Share in Global Market, 2018-2029
1.4.3 Recombinant Hirudin Market Size: China VS Global, 2018-2029
1.5 Recombinant Hirudin Market Dynamics
1.5.1 Recombinant Hirudin Market Drivers
1.5.2 Recombinant Hirudin Market Restraints
1.5.3 Recombinant Hirudin Industry Trends
1.5.4 Recombinant Hirudin Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Recombinant Hirudin Revenue by Company, 2018-2023
2.2 Global Recombinant Hirudin Sales Volume by Company, 2018-2023
2.3 Global Recombinant Hirudin Price by Company, 2018-2023
2.4 Global Recombinant Hirudin Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Recombinant Hirudin Concentration Ratio
2.6 Global Recombinant Hirudin Mergers & Acquisitions, Expansion Plans
2.7 Global Recombinant Hirudin Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Recombinant Hirudin Revenue by Company, 2018-2023
3.2 China Recombinant Hirudin Sales Volume by Company, 2018-2023
3.3 China Recombinant Hirudin Recombinant Hirudin Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Recombinant Hirudin Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Recombinant Hirudin Domestic VS Export
3.6 China Market, Recombinant Hirudin Import & Export
3.6.1 China Market, Recombinant Hirudin Import & Export, 2018-2029
3.6.2 China Recombinant Hirudin Import & Export Trends
3.6.3 Main Sources of China Recombinant Hirudin Import
3.6.4 Export Destination of China Recombinant Hirudin
4 Recombinant Hirudin Production by Region
4.1 Global Recombinant Hirudin Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Recombinant Hirudin Manufacturers
4.3 Global Major Manufacturers, Recombinant Hirudin Capacity Expansion and Future Plans
4.4 Global Recombinant Hirudin Capacity by Region
4.5 Global Recombinant Hirudin Production by Region
4.5.1 Global Recombinant Hirudin Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Recombinant Hirudin Production by Region, 2018-2023
4.5.3 Global Recombinant Hirudin Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Recombinant Hirudin Industry Chain
5.2 Recombinant Hirudin Upstream Analysis
5.2.1 Recombinant Hirudin Core Raw Materials
5.2.2 Main Manufacturers of Recombinant Hirudin Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Recombinant Hirudin Production Mode
5.6 Recombinant Hirudin Procurement Model
5.7 Recombinant Hirudin Industry Sales Model and Sales Channels
5.7.1 Recombinant Hirudin Sales Model
5.7.2 Recombinant Hirudin Typical Distributors
6 Sights by Type
6.1 Recombinant Hirudin Classification
6.1.1 12000ATU/mg
6.1.2 16000ATU/mg
6.2 By Type, Global Recombinant Hirudin Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Recombinant Hirudin Revenue, 2018-2029
6.4 By Type, Global Recombinant Hirudin Sales Volume, 2018-2029
6.5 By Type, Global Recombinant Hirudin Price, 2018-2029
7 Sights by Application
7.1 Recombinant Hirudin Segment by Application
7.1.1 Thrombosis Disease
7.1.2 Tumor Disease
7.2 By Application, Global Recombinant Hirudin Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Recombinant Hirudin Revenue, 2018-2029
7.4 By Application, Global Recombinant Hirudin Sales Volume, 2018-2029
7.5 By Application, Global Recombinant Hirudin Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Recombinant Hirudin Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Recombinant Hirudin Revenue, 2018-2029
8.3 By Region, Global Recombinant Hirudin Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Recombinant Hirudin Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Recombinant Hirudin Market Size Market Share
8.5 Europe
8.5.1 Europe Recombinant Hirudin Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Recombinant Hirudin Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Recombinant Hirudin Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Recombinant Hirudin Market Size Market Share
8.7 South America
8.7.1 South America Recombinant Hirudin Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Recombinant Hirudin Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Recombinant Hirudin Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global Recombinant Hirudin Revenue, 2018-2029
9.3 By Country, Global Recombinant Hirudin Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Recombinant Hirudin Market Size, 2018-2029
9.4.2 By Company, U.S. Recombinant Hirudin Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Recombinant Hirudin Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Recombinant Hirudin Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Recombinant Hirudin Market Size, 2018-2029
9.5.2 By Company, Europe Recombinant Hirudin Sales Volume Market Share, 2022
9.5.3 By Type, Europe Recombinant Hirudin Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Recombinant Hirudin Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Recombinant Hirudin Market Size, 2018-2029
9.6.2 By Company, China Recombinant Hirudin Sales Volume Market Share, 2022
9.6.3 By Type, China Recombinant Hirudin Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Recombinant Hirudin Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Recombinant Hirudin Market Size, 2018-2029
9.7.2 By Company, Japan Recombinant Hirudin Sales Volume Market Share, 2022
9.7.3 By Type, Japan Recombinant Hirudin Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Recombinant Hirudin Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Recombinant Hirudin Market Size, 2018-2029
9.8.2 By Company, South Korea Recombinant Hirudin Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Recombinant Hirudin Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Recombinant Hirudin Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Recombinant Hirudin Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Recombinant Hirudin Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Recombinant Hirudin Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Recombinant Hirudin Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Recombinant Hirudin Market Size, 2018-2029
9.10.2 By Company, India Recombinant Hirudin Sales Volume Market Share, 2022
9.10.3 By Type, India Recombinant Hirudin Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Recombinant Hirudin Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Recombinant Hirudin Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Recombinant Hirudin Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Recombinant Hirudin Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Recombinant Hirudin Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Abbott
10.1.1 Abbott Company Information, Head Office, Market Area and Industry Position
10.1.2 Abbott Recombinant Hirudin Models, Specifications and Application
10.1.3 Abbott Recombinant Hirudin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Abbott Company Profile and Main Business
10.1.5 Abbott Recent Developments
10.2 The Medicines Company
10.2.1 The Medicines Company Company Information, Head Office, Market Area and Industry Position
10.2.2 The Medicines Company Recombinant Hirudin Models, Specifications and Application
10.2.3 The Medicines Company Recombinant Hirudin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 The Medicines Company Company Profile and Main Business
10.2.5 The Medicines Company Recent Developments
10.3 Teva Pharmaceutical
10.3.1 Teva Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.3.2 Teva Pharmaceutical Recombinant Hirudin Models, Specifications and Application
10.3.3 Teva Pharmaceutical Recombinant Hirudin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Teva Pharmaceutical Company Profile and Main Business
10.3.5 Teva Pharmaceutical Recent Developments
10.4 Pfizer
10.4.1 Pfizer Company Information, Head Office, Market Area and Industry Position
10.4.2 Pfizer Recombinant Hirudin Models, Specifications and Application
10.4.3 Pfizer Recombinant Hirudin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Pfizer Company Profile and Main Business
10.4.5 Pfizer Recent Developments
10.5 Pentapharm
10.5.1 Pentapharm Company Information, Head Office, Market Area and Industry Position
10.5.2 Pentapharm Recombinant Hirudin Models, Specifications and Application
10.5.3 Pentapharm Recombinant Hirudin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Pentapharm Company Profile and Main Business
10.5.5 Pentapharm Recent Developments
10.6 PrimeGene
10.6.1 PrimeGene Company Information, Head Office, Market Area and Industry Position
10.6.2 PrimeGene Recombinant Hirudin Models, Specifications and Application
10.6.3 PrimeGene Recombinant Hirudin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 PrimeGene Company Profile and Main Business
10.6.5 PrimeGene Recent Developments
10.7 Aniara Diagnostica
10.7.1 Aniara Diagnostica Company Information, Head Office, Market Area and Industry Position
10.7.2 Aniara Diagnostica Recombinant Hirudin Models, Specifications and Application
10.7.3 Aniara Diagnostica Recombinant Hirudin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Aniara Diagnostica Company Profile and Main Business
10.7.5 Aniara Diagnostica Recent Developments
10.8 Bioassay Technology Laboratory
10.8.1 Bioassay Technology Laboratory Company Information, Head Office, Market Area and Industry Position
10.8.2 Bioassay Technology Laboratory Recombinant Hirudin Models, Specifications and Application
10.8.3 Bioassay Technology Laboratory Recombinant Hirudin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Bioassay Technology Laboratory Company Profile and Main Business
10.8.5 Bioassay Technology Laboratory Recent Developments
10.9 Novus Biologicals
10.9.1 Novus Biologicals Company Information, Head Office, Market Area and Industry Position
10.9.2 Novus Biologicals Recombinant Hirudin Models, Specifications and Application
10.9.3 Novus Biologicals Recombinant Hirudin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Novus Biologicals Company Profile and Main Business
10.9.5 Novus Biologicals Recent Developments
10.10 Merck KGaA
10.10.1 Merck KGaA Company Information, Head Office, Market Area and Industry Position
10.10.2 Merck KGaA Recombinant Hirudin Models, Specifications and Application
10.10.3 Merck KGaA Recombinant Hirudin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Merck KGaA Company Profile and Main Business
10.10.5 Merck KGaA Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables and Figures
Table 1. Recombinant Hirudin Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Recombinant Hirudin Market Restraints
Table 3. Recombinant Hirudin Market Trends
Table 4. Recombinant Hirudin Industry Policy
Table 5. Global Recombinant Hirudin Revenue by Company, 2018-2023, US$ million
Table 6. Global Recombinant Hirudin Revenue Market Share by Company, 2018-2023
Table 7. Global Recombinant Hirudin Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Recombinant Hirudin Sales Volume Market Share by Company, 2018-2023
Table 9. Global Recombinant Hirudin Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Recombinant Hirudin Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Recombinant Hirudin Mergers & Acquisitions, Expansion Plans
Table 12. Global Recombinant Hirudin Manufacturers Product Type
Table 13. China Recombinant Hirudin Revenue by Company, 2018-2023, US$ million
Table 14. China Recombinant Hirudin Revenue Market Share by Company, 2018-2023
Table 15. China Recombinant Hirudin Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Recombinant Hirudin Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Recombinant Hirudin Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Recombinant Hirudin Import & Export Trends
Table 19. Main Sources of China Recombinant Hirudin Import
Table 20. Export Destination of China Recombinant Hirudin
Table 21. Global Headquarters and Manufacturing Base of Recombinant Hirudin Manufacturers
Table 22. Global Major Manufacturers, Recombinant Hirudin Capacity Expansion and Future Plans
Table 23. Global Recombinant Hirudin Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Recombinant Hirudin Production by Region, 2018-2023, (K Units)
Table 25. Global Recombinant Hirudin Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Recombinant Hirudin Upstream (Raw Materials)
Table 27. Global Recombinant Hirudin Typical Customers
Table 28. Recombinant Hirudin Typical Distributors
Table 29. By Type, Global Recombinant Hirudin Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Recombinant Hirudin Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Recombinant Hirudin Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Recombinant Hirudin Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Recombinant Hirudin Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Recombinant Hirudin Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Recombinant Hirudin Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Recombinant Hirudin Revenue Market Share, 2018-2029
Table 37. By Country, Global Recombinant Hirudin Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Recombinant Hirudin Sales Volume Market Share, 2018-2029
Table 39. Abbott Company Information, Head Office, Market Area and Industry Position
Table 40. Abbott Recombinant Hirudin Models, Specifications and Application
Table 41. Abbott Recombinant Hirudin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Abbott Company Profile and Main Business
Table 43. Abbott Recent Developments
Table 44. The Medicines Company Company Information, Head Office, Market Area and Industry Position
Table 45. The Medicines Company Recombinant Hirudin Models, Specifications and Application
Table 46. The Medicines Company Recombinant Hirudin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. The Medicines Company Company Profile and Main Business
Table 48. The Medicines Company Recent Developments
Table 49. Teva Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 50. Teva Pharmaceutical Recombinant Hirudin Models, Specifications and Application
Table 51. Teva Pharmaceutical Recombinant Hirudin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Teva Pharmaceutical Company Profile and Main Business
Table 53. Teva Pharmaceutical Recent Developments
Table 54. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 55. Pfizer Recombinant Hirudin Models, Specifications and Application
Table 56. Pfizer Recombinant Hirudin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Pfizer Company Profile and Main Business
Table 58. Pfizer Recent Developments
Table 59. Pentapharm Company Information, Head Office, Market Area and Industry Position
Table 60. Pentapharm Recombinant Hirudin Models, Specifications and Application
Table 61. Pentapharm Recombinant Hirudin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Pentapharm Company Profile and Main Business
Table 63. Pentapharm Recent Developments
Table 64. PrimeGene Company Information, Head Office, Market Area and Industry Position
Table 65. PrimeGene Recombinant Hirudin Models, Specifications and Application
Table 66. PrimeGene Recombinant Hirudin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. PrimeGene Company Profile and Main Business
Table 68. PrimeGene Recent Developments
Table 69. Aniara Diagnostica Company Information, Head Office, Market Area and Industry Position
Table 70. Aniara Diagnostica Recombinant Hirudin Models, Specifications and Application
Table 71. Aniara Diagnostica Recombinant Hirudin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Aniara Diagnostica Company Profile and Main Business
Table 73. Aniara Diagnostica Recent Developments
Table 74. Bioassay Technology Laboratory Company Information, Head Office, Market Area and Industry Position
Table 75. Bioassay Technology Laboratory Recombinant Hirudin Models, Specifications and Application
Table 76. Bioassay Technology Laboratory Recombinant Hirudin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Bioassay Technology Laboratory Company Profile and Main Business
Table 78. Bioassay Technology Laboratory Recent Developments
Table 79. Novus Biologicals Company Information, Head Office, Market Area and Industry Position
Table 80. Novus Biologicals Recombinant Hirudin Models, Specifications and Application
Table 81. Novus Biologicals Recombinant Hirudin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Novus Biologicals Company Profile and Main Business
Table 83. Novus Biologicals Recent Developments
Table 84. Merck KGaA Company Information, Head Office, Market Area and Industry Position
Table 85. Merck KGaA Recombinant Hirudin Models, Specifications and Application
Table 86. Merck KGaA Recombinant Hirudin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Merck KGaA Company Profile and Main Business
Table 88. Merck KGaA Recent Developments
List of Figure
Figure 1. Recombinant Hirudin Picture
Figure 2. By Revenue, Global Recombinant Hirudin Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Recombinant Hirudin Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Recombinant Hirudin Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Recombinant Hirudin Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Recombinant Hirudin Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Recombinant Hirudin Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Recombinant Hirudin Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Recombinant Hirudin Share of Global Market, 2018-2029
Figure 10. Global Recombinant Hirudin Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Recombinant Hirudin Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Recombinant Hirudin Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Recombinant Hirudin Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Recombinant Hirudin Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Recombinant Hirudin Domestic VS Export, 2022
Figure 16. Global Recombinant Hirudin Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Recombinant Hirudin Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Recombinant Hirudin Production Market Share & Forecast by Region, 2018-2029
Figure 19. Recombinant Hirudin Industry Chain
Figure 20. Recombinant Hirudin Procurement Model
Figure 21. Recombinant Hirudin Sales Model
Figure 22. Recombinant Hirudin Sales Channels, Direct Sales and Distribution
Figure 23. 12000ATU/mg
Figure 24. 16000ATU/mg
Figure 25. By Type, Global Recombinant Hirudin Revenue, 2018-2029, US$ Million
Figure 26. By Type, Global Recombinant Hirudin Revenue Market Share, 2018-2029
Figure 27. By Type, Global Recombinant Hirudin Sales Volume, 2018-2029, (K Units)
Figure 28. By Type, Global Recombinant Hirudin Sales Volume Market Share, 2018-2029
Figure 29. By Type, Global Recombinant Hirudin Price, 2018-2029, (US$/Unit)
Figure 30. Thrombosis Disease
Figure 31. Tumor Disease
Figure 32. By Application, Global Recombinant Hirudin Revenue, 2018-2029, US$ Million
Figure 33. By Application, Global Recombinant Hirudin Revenue Market Share, 2018-2029
Figure 34. By Application, Global Recombinant Hirudin Sales Volume, 2018-2029, (K Units)
Figure 35. By Application, Global Recombinant Hirudin Sales Volume Market Share, 2018-2029
Figure 36. By Application, Global Recombinant Hirudin Price, 2018-2029, (US$/Unit)
Figure 37. By Region, Global Recombinant Hirudin Revenue Market Share, 2018-2029
Figure 38. By Region, Global Recombinant Hirudin Sales Volume Market Share, 2018-2029
Figure 39. North America Recombinant Hirudin Revenue & Forecasts, 2018-2029, US$ Million
Figure 40. By Country, North America Recombinant Hirudin Revenue Market Share, 2022
Figure 41. Europe Recombinant Hirudin Revenue & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, Europe Recombinant Hirudin Revenue Market Share, 2022
Figure 43. Asia Pacific Recombinant Hirudin Revenue & Forecasts, 2018-2029, US$ Million
Figure 44. By Country/Region, Asia Pacific Recombinant Hirudin Revenue Market Share, 2022
Figure 45. South America Recombinant Hirudin Revenue & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, South America Recombinant Hirudin Revenue Market Share, 2022
Figure 47. Middle East & Africa Recombinant Hirudin Revenue & Forecasts, 2018-2029, US$ Million
Figure 48. U.S. Recombinant Hirudin Sales Volume, 2018-2029, (K Units)
Figure 49. By Company, U.S. Recombinant Hirudin Market Share, 2022
Figure 50. By Type, U.S. Recombinant Hirudin Sales Volume Market Share, 2022 VS 2029
Figure 51. By Application, U.S. Recombinant Hirudin Sales Volume Market Share, 2022 VS 2029
Figure 52. Europe Recombinant Hirudin Sales Volume, 2018-2029, (K Units)
Figure 53. By Company, Europe Recombinant Hirudin Market Share, 2022
Figure 54. By Type, Europe Recombinant Hirudin Sales Volume Market Share, 2022 VS 2029
Figure 55. By Application, Europe Recombinant Hirudin Sales Volume Market Share, 2022 VS 2029
Figure 56. China Recombinant Hirudin Sales Volume, 2018-2029, (K Units)
Figure 57. By Company, China Recombinant Hirudin Market Share, 2022
Figure 58. By Type, China Recombinant Hirudin Sales Volume Market Share, 2022 VS 2029
Figure 59. By Application, China Recombinant Hirudin Sales Volume Market Share, 2022 VS 2029
Figure 60. Japan Recombinant Hirudin Sales Volume, 2018-2029, (K Units)
Figure 61. By Company, Japan Recombinant Hirudin Market Share, 2022
Figure 62. By Type, Japan Recombinant Hirudin Sales Volume Market Share, 2022 VS 2029
Figure 63. By Application, Japan Recombinant Hirudin Sales Volume Market Share, 2022 VS 2029
Figure 64. South Korea Recombinant Hirudin Sales Volume, 2018-2029, (K Units)
Figure 65. By Company, South Korea Recombinant Hirudin Market Share, 2022
Figure 66. By Type, South Korea Recombinant Hirudin Sales Volume Market Share, 2022 VS 2029
Figure 67. By Application, South Korea Recombinant Hirudin Sales Volume Market Share, 2022 VS 2029
Figure 68. Southeast Asia Recombinant Hirudin Sales Volume, 2018-2029, (K Units)
Figure 69. By Company, Southeast Asia Recombinant Hirudin Market Share, 2022
Figure 70. By Type, Southeast Asia Recombinant Hirudin Sales Volume Market Share, 2022 VS 2029
Figure 71. By Application, Southeast Asia Recombinant Hirudin Sales Volume Market Share, 2022 VS 2029
Figure 72. India Recombinant Hirudin Sales Volume, 2018-2029, (K Units)
Figure 73. By Company, India Recombinant Hirudin Market Share, 2022
Figure 74. By Type, India Recombinant Hirudin Sales Volume Market Share, 2022 VS 2029
Figure 75. By Application, India Recombinant Hirudin Sales Volume Market Share, 2022 VS 2029
Figure 76. Middle East & Asia Recombinant Hirudin Sales Volume, 2018-2029, (K Units)
Figure 77. By Company, Middle East & Asia Recombinant Hirudin Market Share, 2022
Figure 78. By Type, Middle East & Asia Recombinant Hirudin Sales Volume Market Share, 2022 VS 2029
Figure 79. By Application, Middle East & Asia Recombinant Hirudin Sales Volume Market Share, 2022 VS 2029
Figure 80. Research Methodology
Figure 81. Breakdown of Primary Interviews
Figure 82. Bottom-up Approaches
Figure 83. Top-down Approaches
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets